Clinical Trials Sponsored by Michael Shy

Total 849 results

Shi Ming

Completed

HAIC Plus Lenvatinib and Toripalimab for Advanced HCC

Hepatocellular Carcinoma

China
Shi Ming

Withdrawn

Lenvatinib Plus PD-1 Antibody for Intermediate-stage HCC Beyond Up-to-seven Criteria

Hepatocellular Carcinoma

China
Shi Yang

Unknown

Protective Effect of Statin on Sleep Deprivation

Sleep Deprivation

China
Mina Micheal Anwer Fahmy

Unknown

Repair of Flexor Tendon Injuries With Eight Strand Core Stitch Without Postoperative Splinting

Flexor Tendon Repair
Yongquan Shi

Recruiting

Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy

Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer

China
Shu-Mei Chen

Completed

Elastic Band Resistance Exercise on Glycated Haemoglobin and Muscle Strength, Balance, and Physical Function in Patients With Comorbid Type 2 Diabetes Mellitus and Knee Osteoarthritis

Elastic Band Resistance Exercise With Comorbid Type 2 Diabetes Mellitus and Knee Osteoarthritis

Taiwan
Xiaozheng Shu

Completed

Efficacy and Safety of Crosslinked Hyaluronan Gel for Preventing Intrauterine Adhesion

Intrauterine Adhesion

China
Shi, Patricia, M.D.
Genzyme, a Sanofi Company

Unknown

Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection

Multiple Myeloma | Non-Hodgkins Lymphoma

United States
Caroline Michaela Kistorp
Sanofi

Not yet recruiting

Fibrosis, Inflammation, Oxygenation of Renal Tissue In FabrY Disease (FORTIFY)

Chronic Kidney Diseases | Fabry Disease

Denmark
Michaela Liedtke
Celgene Corporation

Completed

Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

United States
Michaël RACODON

Recruiting

Time of Exercise Re-training With Chronic Obstructive Pulmonary Disease (COPD) (CHRONOBIO)

Respiratory Diseases

France
Michael Wagner
Edgewood Oncology Inc.

Not yet recruiting

BTX-A51 in Patients With Liposarcoma

Liposarcoma | MDM2 Gene Amplification | Metastatic Liposarcoma | Unresectable Liposarcoma | Recurrent Liposarcoma

United States
Michael, Levy M.D.,Ph.D.
Jazz Pharmaceuticals

Not yet recruiting

A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders (SENS-NMO)

Spasticity, Muscle | NMO Spectrum Disorder

United States
Michael Fu
Göteborg University; AstraZeneca

Recruiting

OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure (OPRA-HF)

Heart Failure | Hyperkalemia

Sweden
Michael C Willey
Orthopaedic Trauma Association

Completed

Trauma Screening and Supplementation

Trauma | Wound Heal | Nutritional Deficiency

United States
Michael Boyiadzis
Merck Sharp & Dohme LLC

Completed

A Phase II Study of Pembrolizumab as Post-Remission Treatment of Patients ≥ 60 With AML

Acute Myeloid Leukemia

United States
Prof. Michael B. Zimmermann

Unknown

Iron Long-Term Labelling Study Benin

Iron Absorption

Benin
Norconnect Inc
Michael J. Fox Foundation for Parkinson's Research

Completed

Electromyography Signals as Biomarkers for Parkinson's Disease

Parkinson's Disease

United States
Michael Morse, MD
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer

Testicular Germ Cell Tumor | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Liver Cancer | Gallbladder Cancer

United States
Allyx Therapeutics
Michael J. Fox Foundation for Parkinson's Research

Recruiting

A Study to Assess the Safety of BMS-984923 Compared to Placebo, in People With Parkinson's

Parkinson Disease

United States
Yale University
Fox (Michael J.) Foundation for Parkinson's Research

Recruiting

Ketamine for the Treatment of Depression in Parkinson's Disease (KET-PD)

Depression | Parkinson's Disease

United States
Michael Marchand, MD
Université de Montréal

Recruiting

Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis

Conjunctivitis, Allergic | Conjunctivitis, Vernal

Canada
Michael Frass
Sigmund Freud PrivatUniversitat

Completed

Use of Homeopathy in Patients Suffering From Long COVID-19 (LONGCOVIHOM)

Adjustment Reaction With Physical Symptoms

Austria
Michael Choi
Pharmacyclics LLC.

Active, not recruiting

Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Avanir Pharmaceuticals
Michael J. Fox Foundation for Parkinson's Research

Completed

Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients (LID in PD)

Parkinson's Disease | Dyskinesia

Canada, United States
Michael Cohen-Wolkowiez
The Emmes Company, LLC

Completed

Antibiotic Safety (SCAMP) (SCAMP)

Complicated Intra Abdominal Infections

United States, Canada
Michael Choi
Pharmacyclics LLC.

Withdrawn

Obinutuzumab With High-dose Ibrutinib for the Treatment of Patients With Chronic Lymphocytic Leukemia With Progressive Disease on Single Agent Ibrutinib.

Chronic Lymphocytic Leukemia
Prof. Michael B. Zimmermann

Unknown

Iron Long-Term Labelling Study Switzerland

Iron Absorption

Switzerland
Acorda Therapeutics
Michael J. Fox Foundation for Parkinson's Research

Completed

Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes

Idiopathic Parkinson's Disease

Israel, Serbia, United Kingdom
Bastyr University
Michael J. Fox Foundation for Parkinson's Research

Completed

Phase IIb Study of Intranasal Glutathione in Parkinson's Disease ((in)GSH)

Parkinson's Disease

United States
Michael Rickels
University of Pennsylvania

Completed

Effect of Short Term Atypical Antipsychotic Administration Compared to Placebo on Hepatic Insulin Extraction

Normal Non-fluency

United States
Weintraub, Michael I., MD, FACP, FAAN
Nu-Magnetics Inc.

Unknown

Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral Neuropathy

Diabetic Neuropathies

United States
Murphy, Michael P., MD
Indiana University School of Medicine

Unknown

Safety Study of Using Stem Cells to Stimulate Development of New Blood Vessels in Peripheral Vascular Disease

Peripheral Vascular Diseases

United States
Michel Burnier

Completed

Treatment Adhesion in Dialysis Patients Treated With Cinacalcet (MEMS-cinac)

Hyperparathyroidism | Chronic Kidney Disease

Switzerland
Michal Nowicki

Available

OMS721 Compassionate Use in Patients With Thrombotic Microangiopathy

Thrombotic Microangiopathy
Jean Michel Hascoet
Maternite Regionale Universitaire

Completed

Prematurity Related Risks of Cognitive Impairment at School Age (NEORIS)

Complications of Prematurity

France
Seoul National University Hospital
Sky Labs Inc.

Recruiting

A Ring-type Wearable Device for Atrial Fibrillation Among Ambulatory Patients

Atrial Fibrillation

Korea, Republic of
Hua-Qing Shu

Unknown

The 90% Effective Dose of Nalbuphine in Mechanical Ventilated Patients in the ICU

Pain

China
Shalvata Mental Health Center
SHL Telemedicine Ltd.

Unknown

Measuring the Effect of Remote Monitoring of Treatment Adherence on the Risk of Re-admission of Ambulatory Schizophrenic Patients

Schizophrenia | Schizoaffective Disorder

Israel
Jean Michel Hascoet

Completed

Effect of Prematurity on Renal Function in 5 Years Old Children (SUIVIREIN)

Prematurity of Fetus

France
MICHAEL A GRANDNER
University of Pennsylvania

Recruiting

Addressing Nocturnal Sleep/Wake Effects on Risk of Suicide in Older Adults (ANSWERS-OA)

Sleep Initiation and Maintenance Disorders | Suicidal Ideation

United States
NeuroDerm Ltd.
Michael J. Fox Foundation for Parkinson's Research

Completed

A Safety, Tolerability, and Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease Patients

Parkinson's Disease

Israel
Allyx Therapeutics
Michael J. Fox Foundation for Parkinson's Research

Active, not recruiting

Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers

Dementia | Alzheimer Disease

United States
Alkahest, Inc.
Michael J. Fox Foundation for Parkinson's Research

Completed

A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment

Parkinson Disease

United States, France, Australia
Columbia University
Michael J. Fox Foundation for Parkinson's Research

Completed

Antigen Presentation and Lymphocyte Response in Parkinson's Disease

Parkinson's Disease

United States
Michael Har-Noy
Hadassah Medical Organization

Completed

Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer

Melanoma | Sarcoma | Breast Cancer | Colorectal Cancer | Ovarian Cancer | Prostate Cancer | Non-small Cell Lung Cancer | Solid Tumors Stage II, Stage III and Stage IV

Israel
Michael Abramoff
National Eye Institute (NEI)

Completed

Retinal Therapy Guided by 3D OCT Image Analysis

Age-Related Macular Degeneration | Choroidal Neovascularization

United States
Emory University
Michael J. Fox Foundation for Parkinson's Research

Completed

Defining a PD-specific Breath Fingerprint of Underlying Inflammatory and Neurodegenerative Processes

Parkinson's Disease

United States
Michael Boyiadzis
Merck Sharp & Dohme LLC

Withdrawn

Phase 0- Pilot Study of Pembrolizumab on Immune Cells in Patient With Refractory Acute Myeloid Leukemia

Refractory Acute Myeloid Leukemia

United States
Prof. Michael B. Zimmermann

Unknown

Iron Long-Term Labelling Study Malawi

Iron Absorption

Malawi

Clinical Trials Sponsored by Michael Shy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations